Colin Kellaher, The Wall Street Journal Journalist Profile

Articles

Merck Sets $895 Million Animal-Health Investment in Kansas

6 days ago | marketscreener.com | Colin Kellaher

MERCK & CO., INC. Add to a list Real-time Estimate Cboe BZX 09:42:30 2025-05-08 am EDT 5-day change 1st Jan Change 77.44 USD -2.12% -7.14% -20.47% Merck Sets $895 Million Animal-Health Investment in Kansas Published on 05/08/2025 at 09:33 Merck & Co. plans to invest $895 million to expand its animal-health operations in De Soto, Kan.
ConocoPhillips Names O'Brien Finance Chief as Bullock Retires

6 days ago | marketscreener.com | Colin Kellaher

CONOCOPHILLIPSAdd to a list Market Closed - Nyse 04:00:02 2025-05-07 pm EDT 5-day change 1st Jan Change 87.71 USD +0.09% -1.58% -11.56% ConocoPhillips Names O'Brien Finance Chief as Bullock Retires Published on 05/08/2025 at 07:36 ConocoPhillips' top finance executive, W.L. "Bill" Bullock, is retiring after nearly four decades with the exploration and production company.
ConocoPhillips Names O'Brien Finance Chief as Bullock Retires

6 days ago | tradingview.com | Colin Kellaher

ConocoPhillips Names O'Brien Finance Chief as Bullock RetiresCOPConocoPhillips' top finance executive, W.L. "Bill" Bullock, is retiring after nearly four decades with the exploration and production company. ConocoPhillips said Bullock, who joined the Houston company in 1986 and has been chief financial officer since 2020, will be succeeded on June 1 by Andy O'Brien, currently senior vice president of strategy, commercial, sustainability and technology.
Boston Scientific Names Jon Monson Finance Chief as Dan Brennan Retires

3 weeks ago | tradingview.com | Colin Kellaher

Boston Scientific Names Jon Monson Finance Chief as Dan Brennan RetiresBSXBoston Scientific's top finance executive, Dan Brennan, is retiring after nearly three decades with the medical-technology company. Boston Scientific on Wednesday said Jon Monson, currently senior vice president of investor relations, will succeed Brennan as executive vice president and chief financial officer of the Marlborough, Mass., company, effective June 30.
Regeneron, Sanofi Get FDA Approval For Dupixent in Skin Disease CSU

3 weeks ago | tradingview.com | Colin Kellaher

Regeneron, Sanofi Get FDA Approval For Dupixent in Skin Disease CSUSANREGNRegeneron Pharmaceuticals and Sanofi won U.S. Food and Drug Administration expanded approval of their blockbuster anti-inflammatory drug Dupixent for the inflammatory skin condition chronic spontaneous urticaria, or CSU. Regeneron and Sanofi on Friday said the approval covers Dupixent in people 12 and older who have CSU and remain symptomatic despite histamine-1 antihistamine treatment.
TD Bank's Schwab Investment to Contribute C$74 Million to Bank's 2Q

3 weeks ago | tradingview.com | Colin Kellaher

TD Bank's Schwab Investment to Contribute C$74 Million to Bank's 2QTDToronto-Dominion Bank's stake in Charles Schwab will translate into about 74 million Canadian dollars ($53.5 million) of reported equity in net income of an investment in the bank's fiscal second quarter.
Lockheed Martin Names Company Veteran Evan Scott CFO as Jay Malave Leaves

3 weeks ago | wsj.com | Colin Kellaher

Lockheed Martin’s top finance executive, Jesus “Jay” Malave, is leaving the defense giant to pursue other opportunities. Lockheed on Thursday said veteran finance executive Evan Scott succeeds Malave as senior vice president and chief financial officer, effective immediately. Lockheed named Malave chief financial officer in February 2022, recruiting the executive from smaller rival L3Harris Technologies in a rare transfer between two of the U.S.’s prime defense contractors.
Regeneron Gets FDA Priority Review for Expanded Eylea HD Use

3 weeks ago | marketscreener.com | Colin Kellaher

By Colin Kellaher Regeneron Pharmaceuticals has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its Eylea HD eye drug. Regeneron on Thursday said the application covers Eylea HD for the treatment of macular edema following retinal vein occlusion and for broadening the dosing schedule to include monthly dosing across approved indications.
Lyft to Buy Freenow From BMW, Mercedes for $197 Million -- Update

4 weeks ago | marketscreener.com | Colin Kellaher

By Colin Kellaher Lyft agreed to buy European taxi-hailing app Freenow from German automakers BMW and Mercedes-Benz for about 175 million euros ($197.4 million) in cash, marking the ride-hailing giant's first expansion beyond bikes and scooters outside of North America. Lyft on Tuesday said the deal, which it plans to fund with cash on hand, increases annualized gross bookings by about $1.1 billion and supports its target of delivering roughly $25 billion of gross bookings in 2027.
Ecolab Sets 5% U.S. Trade Surcharge Amid Tariff Impact

4 weeks ago | marketscreener.com | Colin Kellaher

By Colin Kellaher Ecolab is implementing a 5% trade surcharge on all of its solutions and services in the U.S. to help offset a rise in raw material costs spurred by President Trump's sweeping tariff plans.